Home » Newsletters » BioWorld MedTech

BioWorld MedTech

June 23, 2010

View Archived Issues

FDA to accept PMA filing for ev3's embolization device

Report from Europe: Skyline licenses TrovaGene's NMP1 technology for product

Washington roundup: HHS offers $250 million for prevention despite iffy data

Court report: Spectranetics to pay $8.5M to settle upcoming litigation

MDD's food for med-tech thought

MDD/BioWorld win SIPA awards for book, series

Financings roundup: Covidien prices offering for its ev3 acquisition

Agreements/contracts: Mayo Clinic, U. of Illinois compose research alliance

New ventures: BTT says new technology will 'transform' temp measurement

Grants roundup: Apollo Endosurgery gets $5M for new GI cancer applications

Product Briefs

People in the News

MDD's Oncology Extra

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Recombinant vaccine inhibits HBV-associated HCC growth
BioWorld Science
Chronic liver disease and hepatocellular carcinoma (HCC) associated with chronic hepatitis B virus (HBV) are serious health problems in highly endemic areas....